Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities.

Alber J, Alladi S, Bae HJ, Barton DA, Beckett LA, Bell JM, Berman SE, Biessels GJ, Black SE, Bos I, Bowman GL, Brai E, Brickman AM, Callahan BL, Corriveau RA, Fossati S, Gottesman RF, Gustafson DR, Hachinski V, Hayden KM, Helman AM, Hughes TM, Isaacs JD, Jefferson AL, Johnson SC, Kapasi A, Kern S, Kwon JC, Kukolja J, Lee A, Lockhart SN, Murray A, Osborn KE, Power MC, Price BR, Rhodius-Meester HFM, Rondeau JA, Rosen AC, Rosene DL, Schneider JA, Scholtzova H, Shaaban CE, Silva NCBS, Snyder HM, Swardfager W, Troen AM, van Veluw SJ, Vemuri P, Wallin A, Wellington C, Wilcock DM, Xie SX, Hainsworth AH.

Alzheimers Dement (N Y). 2019 Apr 9;5:107-117. doi: 10.1016/j.trci.2019.02.001. eCollection 2019. Review.

2.

White matter hyperintensities are associated with falls in older people with dementia.

Taylor ME, Lord SR, Delbaere K, Wen W, Jiang J, Brodaty H, Kurrle SE, Stefanie Mikolaizak A, Close JCT.

Brain Imaging Behav. 2019 Oct;13(5):1265-1272. doi: 10.1007/s11682-018-9943-8.

PMID:
30145714
3.

White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging.

Barber R, Scheltens P, Gholkar A, Ballard C, McKeith I, Ince P, Perry R, O'Brien J.

J Neurol Neurosurg Psychiatry. 1999 Jul;67(1):66-72.

4.

The impact of silent vascular brain burden in cognitive impairment in Parkinson's disease.

González-Redondo R, Toledo J, Clavero P, Lamet I, García-García D, García-Eulate R, Martínez-Lage P, Rodríguez-Oroz MC.

Eur J Neurol. 2012 Aug;19(8):1100-7. doi: 10.1111/j.1468-1331.2012.03682.x. Epub 2012 Feb 23.

PMID:
22360775
5.

White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?

Provenzano FA, Muraskin J, Tosto G, Narkhede A, Wasserman BT, Griffith EY, Guzman VA, Meier IB, Zimmerman ME, Brickman AM; Alzheimer's Disease Neuroimaging Initiative.

JAMA Neurol. 2013 Apr;70(4):455-61. doi: 10.1001/jamaneurol.2013.1321.

6.

White Matter Hyperintensities and Cognition in Mild Cognitive Impairment and Alzheimer's Disease: A Domain-Specific Meta-Analysis.

van den Berg E, Geerlings MI, Biessels GJ, Nederkoorn PJ, Kloppenborg RP.

J Alzheimers Dis. 2018;63(2):515-527. doi: 10.3233/JAD-170573. Review.

PMID:
29630548
7.

Myelin loss in white matter hyperintensities and normal-appearing white matter of cognitively impaired patients: a quantitative synthetic magnetic resonance imaging study.

Park M, Moon Y, Han SH, Kim HK, Moon WJ.

Eur Radiol. 2019 Sep;29(9):4914-4921. doi: 10.1007/s00330-018-5836-x. Epub 2018 Nov 28.

PMID:
30488109
8.

Severity of White Matter Hyperintensities and Length of Hospital Stay in Patients with Cognitive Impairment: A CREDOS (Clinical Research Center for Dementia of South Korea) Study.

Chang KJ, Lee S, Lee Y, Lee KS, Back JH, Jung YK, Lim KY, Noh JS, Kim HC, Roh HW, Choi SH, Kim SY, Joon Son S, Hong CH.

J Alzheimers Dis. 2015;46(3):719-26. doi: 10.3233/JAD-142823.

PMID:
25854927
9.

White matter hyperintensities, cognitive impairment and dementia: an update.

Prins ND, Scheltens P.

Nat Rev Neurol. 2015 Mar;11(3):157-65. doi: 10.1038/nrneurol.2015.10. Epub 2015 Feb 17. Review.

PMID:
25686760
10.

Characterizing the Penumbras of White Matter Hyperintensities and Their Associations With Cognitive Function in Patients With Subcortical Vascular Mild Cognitive Impairment.

Wu X, Ge X, Du J, Wang Y, Sun Y, Han X, Ding W, Cao M, Xu Q, Zhou Y.

Front Neurol. 2019 Apr 12;10:348. doi: 10.3389/fneur.2019.00348. eCollection 2019.

11.

Longitudinal relaxographic imaging of white matter hyperintensities in the elderly.

Anderson VC, Obayashi JT, Kaye JA, Quinn JF, Berryhill P, Riccelli LP, Peterson D, Rooney WD.

Fluids Barriers CNS. 2014 Oct 20;11:24. doi: 10.1186/2045-8118-11-24. eCollection 2014.

12.

White matter in different regions evolves differently during progression to dementia.

Dadar M, Maranzano J, Ducharme S, Collins DL; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2019 Apr;76:71-79. doi: 10.1016/j.neurobiolaging.2018.12.004. Epub 2018 Dec 21.

PMID:
30703628
13.

Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy.

Staekenborg SS, Koedam EL, Henneman WJ, Stokman P, Barkhof F, Scheltens P, van der Flier WM.

Stroke. 2009 Apr;40(4):1269-74. doi: 10.1161/STROKEAHA.108.531343. Epub 2009 Feb 19.

PMID:
19228848
14.

Factors associated with cerebral white matter hyperintensities in haemodialysis patients.

Naganuma T, Takemoto Y, Shoji T, Shima H, Ishimura E, Okamura M, Nakatani T.

Nephrology (Carlton). 2012 Aug;17(6):561-8. doi: 10.1111/j.1440-1797.2012.01596.x.

PMID:
22429518
15.

White Matter Hyperintensities Predict Cognitive Decline: A Community-Based Study.

Qi X, Tang H, Luo Q, Ding B, Chen J, Cui P, Chen S, Ling H, Ma J.

Can J Neurol Sci. 2019 Jul;46(4):383-388. doi: 10.1017/cjn.2019.47. Epub 2019 May 28.

PMID:
31133080
16.

White matter hyperintensities in mild cognitive impairment: clinical impact of location and interaction with lacunes and medial temporal atrophy.

Yoon B, Shim YS, Cheong HK, Hong YJ, Lee KS, Park KH, Ahn KJ, Kim DJ, Kim YD, Choi SH, Yang DW.

J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):e365-72. doi: 10.1016/j.jstrokecerebrovasdis.2013.12.040. Epub 2014 Feb 28.

PMID:
24589036
17.

Characterizing the white matter hyperintensity penumbra with cerebral blood flow measures.

Promjunyakul N, Lahna D, Kaye JA, Dodge HH, Erten-Lyons D, Rooney WD, Silbert LC.

Neuroimage Clin. 2015 Apr 22;8:224-9. doi: 10.1016/j.nicl.2015.04.012. eCollection 2015.

18.

White matter hyperintensities and imaging patterns of brain ageing in the general population.

Habes M, Erus G, Toledo JB, Zhang T, Bryan N, Launer LJ, Rosseel Y, Janowitz D, Doshi J, Van der Auwera S, von Sarnowski B, Hegenscheid K, Hosten N, Homuth G, Völzke H, Schminke U, Hoffmann W, Grabe HJ, Davatzikos C.

Brain. 2016 Apr;139(Pt 4):1164-79. doi: 10.1093/brain/aww008. Epub 2016 Feb 24.

19.

Subcortical whiter matter hyperintensities within the cholinergic pathways of patients with dementia and parkinsonism.

Park HE, Park IS, Oh YS, Yang DW, Lee KS, Choi HS, Ahn KJ, Kim JS.

J Neurol Sci. 2015;353(1-2):44-8. doi: 10.1016/j.jns.2015.03.046. Epub 2015 Apr 9.

PMID:
25891829
20.

Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimer's disease: comparison to small vessel ischemic vascular dementia.

Doddy RS, Massman PJ, Mawad M, Nance M.

Neuropsychiatry Neuropsychol Behav Neurol. 1998 Oct;11(4):191-9.

PMID:
9845410

Supplemental Content

Support Center